Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2020/12/01
-
Indian UGC (journal)
-
Refrences80
-
Citations33
-
Dimitrios Schizas
-
Aikaterini Mastoraki
-
Eleni Routsi
-
Michail Papapanou
-
Dimitrios Tsapralis
-
Pantelis Vassiliu
-
Konstantinos Toutouzas
-
Evangelos Felekouras
Cite
Schizas, Dimitrios, et al. “Combined Hepatocellular-Cholangiocarcinoma: An Update on Epidemiology, Classification, Diagnosis and Management”. Hepatobiliary &Amp; Pancreatic Diseases International, vol. 19, no. 6, 2020, pp. 515-23, https://doi.org/10.1016/j.hbpd.2020.07.004.
Schizas, D., Mastoraki, A., Routsi, E., Papapanou, M., Tsapralis, D., Vassiliu, P., Toutouzas, K., & Felekouras, E. (2020). Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management. Hepatobiliary &Amp; Pancreatic Diseases International, 19(6), 515-523. https://doi.org/10.1016/j.hbpd.2020.07.004
Schizas, Dimitrios, Aikaterini Mastoraki, Eleni Routsi, Michail Papapanou, Dimitrios Tsapralis, Pantelis Vassiliu, Konstantinos Toutouzas, and Evangelos Felekouras. “Combined Hepatocellular-Cholangiocarcinoma: An Update on Epidemiology, Classification, Diagnosis and Management”. Hepatobiliary &Amp; Pancreatic Diseases International 19, no. 6 (2020): 515-23. https://doi.org/10.1016/j.hbpd.2020.07.004.
Schizas D, Mastoraki A, Routsi E, Papapanou M, Tsapralis D, Vassiliu P, et al. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management. Hepatobiliary & Pancreatic Diseases International. 2020;19(6):515-23.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the digestive system
Gastroenterology
Medicine
Medicine (General)
You May Also Like
- Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients
- Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents
- A comprehensive review of superior mesenteric artery syndrome
- 1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
- Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection | Journal of the Formosan Medical Association |
| 13 | 2020 |
| The 2019 WHO classification of tumours of the digestive system | Histopathology |
| 1,773 | 2020 |
| Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma | Journal of Hepatology |
| 290 | 2020 |
| New systemic agents for hepatocellular carcinoma: an update 2020 | Current Opinion in Gastroenterology |
| 2020 | |
Genomic profiling of combined hepatocellular‐cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma | The Journal of Pathology |
| 72 | 2019 |
Refrences Analysis
The category
Medicine: Medicine (General) 53
is the most frequently represented among the references in this article. It primarily includes studies from Journal of Hepatology and Annals of Surgical Oncology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension | Hepatobiliary & Pancreatic Diseases International |
| 2024 | |
| Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies? | Hepatobiliary & Pancreatic Diseases International |
| 2024 | |
| Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Abdominal Radiology |
| 1 | 2023 |
The role of myeloid-derived suppressor cells in liver cancer | Discover Oncology |
| 2 | 2023 |
| Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data | European Journal of Radiology |
| 1 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 30
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma and was published in 2021. The most recent citation comes from a 2024 study titled Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?. This article reached its peak citation in 2021, with 12 citations. It has been cited in 26 different journals, 30% of which are open access. Among related journals, the Cancers cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.